Spironolactone Tablet, Film Coated
Product Images NDC 43063-835

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 43063-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063835 Label (43063835)

Label for Spironolactone USP 100 mg film-coated tablets in a 30 tablet package, by PD-Rx Pharmaceuticals, Inc. The label includes dosage instructions space, lot number C22B83, expiration date 12/2023, and multiple barcodes. The label features a green RX only warning and instructions to keep out of reach of children.*

FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)

A Kaplan-Meier survival curve graph comparing the probability over time (months) between Spironolactone and Placebo groups. The graph shows two lines, one for Spironolactone (n=822) and one for Placebo (n=841), with the Spironolactone group consistently displaying higher probability. The log-rank test p-value is less than 0.001, indicating statistical significance.*

FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)

A forest plot displaying hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a clinical study comparing spironolactone and placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker use. The plot visualizes whether spironolactone or placebo is favored for each subgroup based on HR values.*

FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical structure diagram of spironolactone, showing the molecular framework with labeled functional groups typical for this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.